• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    South Korea Stem Cell Therapy Market

    ID: MRFR/Pharma/51402-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    South Korea Stem Cell Therapy Market Research Report By Application (Orthopedic, Cardiovascular, Neurological, Dermatological, Dental), By Type of Stem Cells (Embryonic Stem Cells, Adult Stem Cells, Induced Pluripotent Stem Cells, Mesenchymal Stem Cells), By Therapeutic Area (Regenerative Medicine, Cancer Treatment, Autoimmune Diseases, Genetic Disorders), and By Procedure Type (Surgical Procedures, Non-surgical Procedures)-Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    South Korea Stem Cell Therapy Market Research Report-Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    South Korea Stem Cell Therapy Market Summary

    The South Korea Stem Cell Therapy market is projected to grow significantly from 408 USD Million in 2024 to 1012 USD Million by 2035.

    Key Market Trends & Highlights

    South Korea Stem Cell Therapy Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 8.61% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 1012 USD Million, indicating robust growth potential.
    • In 2024, the market is valued at 408 USD Million, showcasing a solid foundation for future expansion.
    • Growing adoption of advanced therapeutic techniques due to increasing prevalence of chronic diseases is a major market driver.

    Market Size & Forecast

    2024 Market Size 408 (USD Million)
    2035 Market Size 1012 (USD Million)
    CAGR (2025-2035) 8.61%

    Major Players

    Medytox, Samsung Biologics, Korea National Health Insurance Service, Medipost, Hansoh Pharmaceutical, CHA Biotech, Somagenics, Celltrion, Osstem Implant, Kantech, Hugel, Regenetek, Green Cross Corporation, TiumBio, Curecell

    South Korea Stem Cell Therapy Market Trends

    The market for stem cell therapy in South Korea is expanding significantly due to a number of important considerations. A significant factor driving the industry is the government's strong support for regenerative medicine, which is demonstrated by programs to create research frameworks and fund clinical studies.

    Research and development efforts in the field of stem cell therapies have been encouraged by the Korean Ministry of Health and Welfare, which has been aggressively pushing policies to simplify laws in this area. There is widespread excitement for new developments in stem cell therapies due to technological breakthroughs and growing partnerships between corporate businesses and academic institutions.

    The nation's increasing need for personalised medicine and cutting-edge treatments present opportunities to be investigated. South Korea's advanced biotechnology investments and well-established healthcare system make it an ideal place to explore innovative therapies for a range of illnesses.

    Clinical research on the use of stem cells to treat degenerative diseases, chronic illnesses, and injuries has increased recently, according to trends. Interest in stem cell treatments has increased as a result of the rising incidence of heart disease and diabetes in South Korea.

    Furthermore, the market is expanding generally due to rising public acceptance and understanding of these cutting-edge therapeutic choices. The future of stem cell therapy in the region is anticipated to be significantly shaped by continued developments and regulatory backing, as South Korea maintains its position as a biotechnology pioneer.

    South Korea Stem Cell Therapy Market Drivers

    Market Segment Insights

    Stem Cell Therapy Market Application Insights

    The South Korea Stem Cell Therapy Market is experiencing substantial growth, particularly in the Application segment, which plays a crucial role in advancing healthcare solutions across various medical fields. This segment encompasses several domains, including Orthopedic, Cardiovascular, Neurological, Dermatological, and Dental applications, each contributing significantly to the overall market dynamics.

    In the Orthopedic application area, stem cell therapies are leveraged to treat joint disorders and enhance healing processes, making it a pivotal segment due to the increasing prevalence of musculoskeletal conditions.

    Cardiovascular applications of stem cell therapies are garnering attention for their potential in regenerating damaged heart tissues, addressing a critical healthcare challenge as heart diseases remain a leading cause of mortality in South Korea.

    Neurological applications showcase promising advancements, especially in treating conditions like spinal cord injuries and degenerative diseases such as Parkinson's and Alzheimer's, which are becoming more prevalent with an aging population.

    The Dermatological field is also witnessing innovative uses of stem cells to promote skin regeneration and repair, driven by increasing interest in cosmetic applications and wound healing solutions. Meanwhile, the Dental segment is emerging with applications focused on tooth regeneration and the treatment of periodontal diseases, reflecting the growing demand for innovative oral health solutions.

    Stem Cell Therapy Market Type of Stem Cells Insights

    The Type of Stem Cells segment within the South Korea Stem Cell Therapy Market plays a crucial role in advancing regenerative medicine and therapy approaches across various diseases. Embryonic Stem Cells are often recognized for their ability to differentiate into any cell type, making them vital for extensive research and potential therapeutic uses.

    Adult Stem Cells, primarily sourced from tissues like bone marrow, have gained attention due to their lower ethical concerns and established applications in treating conditions such as hematological diseases.

    Induced Pluripotent Stem Cells offer exciting opportunities by reprogramming adult cells into a pluripotent state, thus enabling personalized medicine and disease modeling without ethical issues associated with embryonic sources. Mesenchymal Stem Cells have also seen a rise in prominence due to their immunomodulatory properties and potential in treating various inflammatory diseases.

    The interplay between these types highlights a diverse landscape in the South Korea Stem Cell Therapy Market, with ongoing Research and Development driving innovations and addressing significant medical needs, while challenges such as regulatory hurdles and public perception remain a focus for stakeholders.

    This segment reflects a dynamic growth area, supported by a strong commitment from local institutions and government to foster advancements in stem cell research and application.

    Stem Cell Therapy Market Therapeutic Area Insights

    The South Korea Stem Cell Therapy Market is experiencing substantial growth, particularly in the Therapeutic Area, which encompasses various critical applications. Among these applications, regenerative medicine has emerged as a key area, focusing on tissue repair and organ regeneration, fueled by advancements in cellular technologies.

    Cancer treatment continues to be a significant focus due to the increasing prevalence of various cancers and the demand for innovative therapies, offering hope for patients with limited options. Similarly, therapies aimed at autoimmune diseases are gaining traction, addressing the growing needs of a population affected by conditions such as rheumatoid arthritis and lupus.

    Genetic disorders represent another vital aspect, where stem cell interventions could alter the treatment landscape, providing new possibilities for managing inherited conditions.

    The convergence of innovative Research and Development initiatives and supportive regulations by the South Korean government lays the groundwork for extensive advancements across these therapeutic applications, driving future growth in the South Korea Stem Cell Therapy Market.

    With a well-established healthcare infrastructure and a growing emphasis on personalized medicine, the country is poised to be a leader in stem cell therapies, showcasing its potential for breakthroughs in these therapeutic areas.

    Stem Cell Therapy Market Procedure Type Insights

    The South Korea Stem Cell Therapy Market is primarily segmented by Procedure Type, encompassing Surgical Procedures and Non-surgical Procedures. Surgical Procedures often involve harvesting stem cells and may lead to significant advancements in treating various chronic diseases and conditions, providing enhanced therapeutic outcomes.

    Meanwhile, Non-surgical Procedures primarily focus on minimally invasive techniques, appealing to patients seeking lower-risk treatment options with quicker recovery times. This diversity within the Procedure Type segment is important as it accommodates a wide range of patient preferences and clinical needs, thereby fostering greater access to stem cell therapies across the region.

    South Korea's advanced healthcare infrastructure and increasing investments in Research and Development further support growth in these procedures. Furthermore, increasing public awareness about the benefits of stem cell therapies is driving demand across both segments, allowing for innovative applications in regenerative medicine and personalized treatment solutions.

    The blending of these procedures demonstrates the resilience and adaptability of the South Korea Stem Cell Therapy Market, highlighting the significant potential for both established and emerging therapeutic techniques in improving patient care.

    Get more detailed insights about South Korea Stem Cell Therapy Market Research Report-Forecast to 2035

    Request Free Sample

    Regional Insights

    Key Players and Competitive Insights

    The South Korea Stem Cell Therapy Market is witnessing rapid growth, driven by advancements in biotechnology and increased investment in research and development. The competitive landscape is characterized by a surge in innovative therapies targeting various diseases and conditions, alongside a robust regulatory framework that supports clinical research and product commercialization.

    South Korea has established itself as a prominent hub for stem cell research, thanks to strong government support, a highly skilled workforce, and collaboration between academia and industry. This environment fosters competition among local and global players as they strive to capture market share through unique therapeutic solutions and strategic partnerships.

    Medytox has emerged as a key player in the South Korea Stem Cell Therapy Market, focusing on the development of innovative therapies that leverage its expertise in biological research. The company has successfully positioned itself by investing heavily in R&D and establishing a strong portfolio of stem cell-based treatment options that cater to unmet medical needs.

    Medytox is recognized for its commitment to quality and safety, reflected in its compliance with stringent regulatory standards. Its strengths lie in its innovative approach to stem cell therapy, which allows for treating a wide range of conditions effectively. This competitive edge, coupled with a growing reputation in the biopharmaceutical sector, positions Medytox favorably within the South Korean market.

    Samsung Biologics has also carved out a significant presence in the South Korea Stem Cell Therapy Market, focusing on contract development and manufacturing of biopharmaceutical products.

    The company provides a comprehensive range of services, including cell line development, process development, and large-scale commercial manufacturing, which are crucial for the rapid commercialization of stem cell therapies.

    Samsung Biologics has been noted for its advanced manufacturing capabilities that ensure high-quality production and scalability, providing a valuable resource for companies venturing into stem cell therapy. Its ongoing investments in state-of-the-art facilities and technologies enhance its competitive advantage.

    Furthermore, Samsung Biologics actively pursues strategic partnerships and potential mergers and acquisitions to expand its market reach and enhance its service offerings within the South Korean biotechnology landscape.

    Key Companies in the South Korea Stem Cell Therapy Market market include

    Industry Developments

    Market Segmentation

    Outlook

    • Surgical Procedures
    • Non-surgical Procedures

    Stem Cell Therapy Market Application Outlook

    • Orthopedic
    • Cardiovascular
    • Neurological
    • Dermatological
    • Dental

    Stem Cell Therapy Market Procedure Type Outlook

    • Surgical Procedures
    • Non-surgical Procedures

    Stem Cell Therapy Market Therapeutic Area Outlook

    • Regenerative Medicine
    • Cancer Treatment
    • Autoimmune Diseases
    • Genetic Disorders

    Stem Cell Therapy Market Type of Stem Cells Outlook

    • Embryonic Stem Cells
    • Adult Stem Cells
    • Induced Pluripotent Stem Cells
    • Mesenchymal Stem Cells

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 362.75(USD Million)
    MARKET SIZE 2024 408.0(USD Million)
    MARKET SIZE 2035 1012.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 8.609% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Medytox, Samsung Biologics, Korea National Health Insurance Service, Medipost, Hansoh Pharmaceutical, CHA Biotech, Somagenics, Celltrion, Osstem Implant, Kantech, Hugel, Regenetek, Green Cross Corporation, TiumBio, Curecell
    SEGMENTS COVERED Application, Type of Stem Cells, Therapeutic Area, Procedure Type
    KEY MARKET OPPORTUNITIES Regenerative medicine advancements, Increasing chronic disease prevalence, Government funding and support, Growing research collaborations, Rising demand for personalized therapies
    KEY MARKET DYNAMICS regulatory approvals, technological advancements, increasing healthcare expenditure, growing prevalence of chronic diseases, rising consumer awareness
    COUNTRIES COVERED South Korea

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch
    Leave a Comment

    FAQs

    What is the expected market size of the South Korea Stem Cell Therapy Market in 2024?

    The South Korea Stem Cell Therapy Market is expected to be valued at 408.0 million USD in 2024.

    What is the projected market value for the South Korea Stem Cell Therapy Market by 2035?

    By 2035, the South Korea Stem Cell Therapy Market is projected to reach a total value of 1012.0 million USD.

    What is the expected compound annual growth rate (CAGR) for the South Korea Stem Cell Therapy Market from 2025 to 2035?

    The market is expected to show a CAGR of 8.609% during the period from 2025 to 2035.

    Which segment of the South Korea Stem Cell Therapy Market is expected to dominate in 2035?

    The Orthopedic segment is expected to dominate the market in 2035, valued at 245.0 million USD.

    What will the value of the Cardiovascular segment be in the South Korea Stem Cell Therapy Market by 2035?

    The Cardiovascular segment is expected to be valued at 210.0 million USD in 2035.

    How much is the Neurological application market expected to grow by 2035?

    The Neurological application market is projected to grow to 220.0 million USD by 2035.

    Who are the major players in the South Korea Stem Cell Therapy Market?

    Key players include Medytox, Samsung Biologics, Medipost, and CHA Biotech among others.

    What will the Dermatological application market be valued at in 2035?

    The Dermatological application market is expected to be valued at 159.0 million USD in 2035.

    What is the estimated value of the Dental application segment in 2024?

    The Dental application segment is estimated to be valued at 60.0 million USD in 2024.

    What are the growth opportunities in the South Korea Stem Cell Therapy Market going forward?

    The market offers growth opportunities due to increasing advancements in technology and rising healthcare investments.

    1. EXECUTIVE
    2. SUMMARY
    3. Market Overview
    4. Key Findings
    5. Market Segmentation
    6. Competitive Landscape
    7. Challenges and Opportunities
    8. Future Outlook
    9. MARKET INTRODUCTION
    10. Definition
    11. Scope of the study
    12. Research Objective
    13. Assumption
    14. Limitations
    15. RESEARCH
    16. METHODOLOGY
    17. Overview
    18. Data
    19. Mining
    20. Secondary Research
    21. Primary
    22. Research
    23. Primary Interviews and Information Gathering
    24. Process
    25. Breakdown of Primary Respondents
    26. Forecasting
    27. Model
    28. Market Size Estimation
    29. Bottom-Up
    30. Approach
    31. Top-Down Approach
    32. Data
    33. Triangulation
    34. Validation
    35. MARKET
    36. DYNAMICS
    37. Overview
    38. Drivers
    39. Restraints
    40. Opportunities
    41. MARKET FACTOR ANALYSIS
    42. Value chain Analysis
    43. Porter's
    44. Five Forces Analysis
    45. Bargaining Power of Suppliers
    46. Bargaining
    47. Power of Buyers
    48. Threat of New Entrants
    49. Threat
    50. of Substitutes
    51. Intensity of Rivalry
    52. COVID-19
    53. Impact Analysis
    54. Market Impact Analysis
    55. Regional
    56. Impact
    57. Opportunity and Threat Analysis
    58. South
    59. Korea Stem Cell Therapy Market, BY Application (USD Million)
    60. Orthopedic
    61. Cardiovascular
    62. Neurological
    63. Dermatological
    64. Dental
    65. South
    66. Korea Stem Cell Therapy Market, BY Type of Stem Cells (USD Million)
    67. Embryonic
    68. Stem Cells
    69. Adult Stem Cells
    70. Induced
    71. Pluripotent Stem Cells
    72. Mesenchymal Stem Cells
    73. South
    74. Korea Stem Cell Therapy Market, BY Therapeutic Area (USD Million)
    75. Regenerative
    76. Medicine
    77. Cancer Treatment
    78. Autoimmune
    79. Diseases
    80. Genetic Disorders
    81. South
    82. Korea Stem Cell Therapy Market, BY Procedure Type (USD Million)
    83. Surgical
    84. Procedures
    85. Non-surgical Procedures
    86. Competitive Landscape
    87. Overview
    88. Competitive
    89. Analysis
    90. Market share Analysis
    91. Major
    92. Growth Strategy in the Stem Cell Therapy Market
    93. Competitive
    94. Benchmarking
    95. Leading Players in Terms of Number of Developments
    96. in the Stem Cell Therapy Market
    97. Key developments and
    98. growth strategies
    99. New Product Launch/Service Deployment
    100. Merger
    101. & Acquisitions
    102. Joint Ventures
    103. Major
    104. Players Financial Matrix
    105. Sales and Operating Income
    106. Major
    107. Players R&D Expenditure. 2023
    108. Company
    109. Profiles
    110. Medytox
    111. Financial
    112. Overview
    113. Products Offered
    114. Key
    115. Developments
    116. SWOT Analysis
    117. Key
    118. Strategies
    119. Samsung Biologics
    120. Financial
    121. Overview
    122. Products Offered
    123. Key
    124. Developments
    125. SWOT Analysis
    126. Key
    127. Strategies
    128. Korea National Health Insurance
    129. Service
    130. Financial Overview
    131. Products
    132. Offered
    133. Key Developments
    134. SWOT
    135. Analysis
    136. Key Strategies
    137. Medipost
    138. Financial
    139. Overview
    140. Products Offered
    141. Key
    142. Developments
    143. SWOT Analysis
    144. Key
    145. Strategies
    146. Hansoh Pharmaceutical
    147. Financial
    148. Overview
    149. Products Offered
    150. Key
    151. Developments
    152. SWOT Analysis
    153. Key
    154. Strategies
    155. CHA Biotech
    156. Financial
    157. Overview
    158. Products Offered
    159. Key
    160. Developments
    161. SWOT Analysis
    162. Key
    163. Strategies
    164. Somagenics
    165. Financial
    166. Overview
    167. Products Offered
    168. Key
    169. Developments
    170. SWOT Analysis
    171. Key
    172. Strategies
    173. Celltrion
    174. Financial
    175. Overview
    176. Products Offered
    177. Key
    178. Developments
    179. SWOT Analysis
    180. Key
    181. Strategies
    182. Osstem Implant
    183. Financial
    184. Overview
    185. Products Offered
    186. Key
    187. Developments
    188. SWOT Analysis
    189. Key
    190. Strategies
    191. Kantech
    192. Financial
    193. Overview
    194. Products Offered
    195. Key
    196. Developments
    197. SWOT Analysis
    198. Key
    199. Strategies
    200. Hugel
    201. Financial
    202. Overview
    203. Products Offered
    204. Key
    205. Developments
    206. SWOT Analysis
    207. Key
    208. Strategies
    209. Regenetek
    210. Financial
    211. Overview
    212. Products Offered
    213. Key
    214. Developments
    215. SWOT Analysis
    216. Key
    217. Strategies
    218. Green Cross Corporation
    219. Financial
    220. Overview
    221. Products Offered
    222. Key
    223. Developments
    224. SWOT Analysis
    225. Key
    226. Strategies
    227. TiumBio
    228. Financial
    229. Overview
    230. Products Offered
    231. Key
    232. Developments
    233. SWOT Analysis
    234. Key
    235. Strategies
    236. Curecell
    237. Financial
    238. Overview
    239. Products Offered
    240. Key
    241. Developments
    242. SWOT Analysis
    243. Key
    244. Strategies
    245. References
    246. Related
    247. Reports
    248. LIST
    249. OF ASSUMPTIONS
    250. South Korea Stem Cell Therapy Market SIZE
    251. ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
    252. South
    253. Korea Stem Cell Therapy Market SIZE ESTIMATES & FORECAST, BY TYPE OF STEM CELLS,
    254. 2035 (USD Billions)
    255. South Korea Stem Cell Therapy
    256. Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD Billions)
    257. South
    258. Korea Stem Cell Therapy Market SIZE ESTIMATES & FORECAST, BY PROCEDURE TYPE,
    259. 2035 (USD Billions)
    260. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    261. ACQUISITION/PARTNERSHIP
    262. LIST
    263. Of figures
    264. MARKET SYNOPSIS
    265. SOUTH
    266. KOREA STEM CELL THERAPY MARKET ANALYSIS BY APPLICATION
    267. SOUTH
    268. KOREA STEM CELL THERAPY MARKET ANALYSIS BY TYPE OF STEM CELLS
    269. SOUTH
    270. KOREA STEM CELL THERAPY MARKET ANALYSIS BY THERAPEUTIC AREA
    271. SOUTH
    272. KOREA STEM CELL THERAPY MARKET ANALYSIS BY PROCEDURE TYPE
    273. KEY
    274. BUYING CRITERIA OF STEM CELL THERAPY MARKET
    275. RESEARCH
    276. PROCESS OF MRFR
    277. DRO ANALYSIS OF STEM CELL THERAPY MARKET
    278. DRIVERS
    279. IMPACT ANALYSIS: STEM CELL THERAPY MARKET
    280. RESTRAINTS
    281. IMPACT ANALYSIS: STEM CELL THERAPY MARKET
    282. SUPPLY / VALUE
    283. CHAIN: STEM CELL THERAPY MARKET
    284. STEM CELL THERAPY MARKET,
    285. BY APPLICATION, 2025 (% SHARE)
    286. STEM CELL THERAPY MARKET,
    287. BY APPLICATION, 2019 TO 2035 (USD Billions)
    288. STEM CELL
    289. THERAPY MARKET, BY TYPE OF STEM CELLS, 2025 (% SHARE)
    290. STEM
    291. CELL THERAPY MARKET, BY TYPE OF STEM CELLS, 2019 TO 2035 (USD Billions)
    292. STEM
    293. CELL THERAPY MARKET, BY THERAPEUTIC AREA, 2025 (% SHARE)
    294. STEM
    295. CELL THERAPY MARKET, BY THERAPEUTIC AREA, 2019 TO 2035 (USD Billions)
    296. STEM
    297. CELL THERAPY MARKET, BY PROCEDURE TYPE, 2025 (% SHARE)
    298. STEM
    299. CELL THERAPY MARKET, BY PROCEDURE TYPE, 2019 TO 2035 (USD Billions)
    300. BENCHMARKING
    301. OF MAJOR COMPETITORS

    South Korea Stem Cell Therapy Market Segmentation

    • Stem Cell Therapy Market By Application (USD Million, 2019-2035)

      • Orthopedic
      • Cardiovascular
      • Neurological
      • Dermatological
      • Dental

     

    • Stem Cell Therapy Market By Type of Stem Cells (USD Million, 2019-2035)

      • Embryonic Stem Cells
      • Adult Stem Cells
      • Induced Pluripotent Stem Cells
      • Mesenchymal Stem Cells

     

    • Stem Cell Therapy Market By Therapeutic Area (USD Million, 2019-2035)

      • Regenerative Medicine
      • Cancer Treatment
      • Autoimmune Diseases
      • Genetic Disorders

     

    • Stem Cell Therapy Market By Procedure Type (USD Million, 2019-2035)

      • Surgical Procedures
      • Non-surgical Procedures
    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027